1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Fundación Senefro: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. Paricalcitol, Calcifediol - Secondary Hyperparathyroidism Due to Renal Causes | Phase 4 | Completed | Fundación Senefro | 148 | 2014-01-01 | 2018-11-19 |
Hyperparathyroidism (1) · Hyperparathyroidism, Secondary (1)
Calcifediol (1) · paricalcitol (1)
Spain (1)